Skip to Content

Novel 660 300 mg (Trimethobenzamide Hydrochloride 300 mg)

Pill with imprint Novel 660 300 mg is Purple, Capsule-shape and has been identified as Trimethobenzamide Hydrochloride 300 mg. It is supplied by Gavis Pharmaceuticals.

Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy. Trimethobenzamide 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Novel 660 300 mg

Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg
Trimethobenzamide hydrochloride 300 mg Novel 660 300 mg

Trimethobenzamide Hydrochloride

Imprint:
Novel 660 300 mg
Strength:
300 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gavis Pharmaceuticals
Inactive Ingredients:
lactose monohydrate
magnesium stearate
corn starch
D&C Red No. 28
gelatin
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
soya lecithin
water
shellac
ethylene glycol monoethyl ether
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide